A scale to assess activities of daily living in persons affected by leprosy

Leprosy Review

Volumn 70, Issue 3, 1999, Pages 314-323

  Van Brakel, W H ^a,c   Anderson, A M ^a   Worpel F C ^a   Saiju, R ^a   Bk, H B ^a   Sherpa, S ^a   Sunwar, S K ^a   Gurung, J ^a   De Boer, M ^b   Scholten, E ^b  

^a International Nepal Fellowship   (Nepal)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c c/o TLM Nepal ^*  (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DIAGNOSTIC ACCURACY; DISABILITY; HUMAN; HUMAN RELATION; LEPROSY; MAJOR CLINICAL STUDY; NEPAL; OBSERVER VARIATION; OCCUPATION; QUESTIONNAIRE; RELIABILITY; RURAL AREA;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; FEMALE; GUIDELINES; HUMANS; LEPROSY; MALE; MIDDLE AGED; NEPAL; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 17444454234     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Dastur DK. Pathology and pathogenesis of predilective sites of nerve damage in leprous neuritis. Nerves in the arm and the face. Neurosurg Rev, 1983; 6: 139-152.
2. Job CK. Nerve damage in leprosy. Int J Lepr, 1989; 57: 532-539.
3. van Brakel WH, Khawas IB. Nerve damage in leprosy: an epidemiological study of 396 patients in West Nepal - part 1: definitions, methods and frequencies. Lepr Rev, 1994; 65: 204-221.
4. ILEP. Prevention of disability. Guidelines for leprosy control programmes. London: ILEP, 1993.
5. Watson JM. Preventing disability in leprosy patients. London: The Leprosy Mission International, 1986.
6. ICIDH-2: International Classification of Impairments, Activities, and Participation. A Manual of Dimensions of Disablement and Functioning. Beta-1 draft for field trials. Geneva: World Health Organization, 1997.
7. World Health Organisation. Global case detection trend in leprosy. Weekly Epidemiol Rec, 1997; 72: 173-180.
8. Palande DD. Nerve involvement in leprosy - prevention and management of deformities:need for a paradigm-shift. Lepr Rev, 1994; 65: 161-164.
9. World Health Organisation. Leprosy disabilities: magnitude of the problem. Weekly Epidemiol Rec, 1995; 70: 269-276.
10. Srinivasan H. To control leprosy as if the patient mattered. Ind J Lepr, 1984; 56: 386-395.
11. Brandsma JW, Heerkens YF, Lakerveld-Heyl K, van Ravensberg CD. The international classification of impairments, disabilities and handicaps in leprosy-control projects. Lepr Rev, 1992; 63: 337-344.
12. Smith WCS. The epidemiology of disability in leprosy including risk factors. Lepr Rev, 1992; 63: Supplement 23s-30s.
13. van Bennekom CAM, Jelles F, Lankhorst GJ. Rehabilitation Activities Profile: the ICIDH as a framework for a problem-oriented assessment method in rehabilitation medicine. Disabil Rehabil, 1995; 17: 169-175.
14. McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. New York: Oxford University Press, 1987.
15. Jiwa-Boerrigter H, Van Engelen HGM, Lankhorst GJ. Application of the ICIDH in rehabilitation medicine. Int Disabil Studies, 1990; 12: 17-19.
16. Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil, 1987; 1: 6-18.
17. Mahoney FJ, Barthel DW. Functional evaluation: the Barthel index. Md State Med J, 1965; 14: 61-65.
18. Salèn BA, Spangfort EV, Nygren ÅL, Nordemar R. The disability rating index: an instrument for the assessment of disability in clinical settings. J Clin Epidemiol, 1994; 47: 1423-1434.
19. Streiner DL, Norman GR. Health measurement scales. A practical guide to their development and use. Oxford: Oxford University Press, 1989.
20. Laman H, Lankhorst GJ. Subjective weighting of disability: an approach to quality of life assessment in rehabilitation. Disab Rehabil, 1994; 16: 198-204.
21. WHO Expert Committee on Leprosy. Sixth Report. 768. 1988. Geneva: WHO Technical Report Series.
22. Kirkwood BR. Essentials of medical statistics. Oxford: Blackwell Scientific Publications, 1988.
23. Cohen J. Weighted kappa:nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull, 1968; 70: 213-220.
24. van Brakel WH, van LM, Kets M, Drever W, Khawas IB, Gurung KS. Intra-and inter-tester reliability of sensibility testing in leprosy. Int J Lepr, 1996; 64: 287-298.
25. van Brakel WH, Anderson AMA. Impairment and disability in leprosy: in search of the missing link. Ind J Lepr, 1997; 69: 361-376.
26. Jopling WH. Leprosy stigma [editorial]. Lepr Rev ,1991; 62: 1-12.
27. Frist T. 'Don't treat me like I have leprosy!'. London: TALMILEP, 1996.
28. Hasan S. A survey of leprosy deformities among the patients of Hyderabad city. Lepr Ind, 1977; 49: 393-399.
29. Kushwah SS, Govila AK, Kushwah J. An epidemiological study of disabilities among leprosy patients attending leprosy clinic in Gwalior. Lepr Ind, 1981; 53: 240-247.
30. Girdhar M, Arora SK, Mohan L, Mukhija RD. Pattern of leprosy disabilities in Gorakhpur (Uttar Pradesh). Ind J Lepr, 1989; 61:503-513.
31. Schipper A, Lubbers WJ, Hogeweg M, de Soldenhoff R. Disabilities of hands,feet and eyes in newly diagnosed leprosy patients in eastern Nepal. Lepr Rev, 1994; 65: 239-247.
32. Srinivasan H. Prevention of disabilities in patients with leprosy. A practical guide. Geneva: World Health Organisation, 1993;
33. Radhakrishna S, Nair GK. Association between regularity in dapsone (DDS) treatment and development of deformity. Int J Lepr, 1987; 55: 425-434.
34. Pönnighaus JM, Boerrigter G. Are 18 doses of WHO/MDT sufficient for multibacillary leprosy; results of a trial in Malawi. Int J Lepr, 1995; 63: 1-7.
35. Richardus JH, Finlay KM, Croft RP, Smith WCS. Nerve function impairment in leprosy at diagnosis and at completion of MDT: a retrospective cohort study of 786 patients in Bangladesh. Lepr Rev, 1996; 67: 297-305.
36. Reed NK, van Brakel WH, Reed DS. Progress of impairment scores following the commencement of chemotherapy in MB leprosy patients. Int J Lepr, 1997; 65: 328-336.
37. Brand PW. The reconstruction of the hand in leprosy. Ann R Coll Eng, 1952; 11: 350-361.
38. Brand PW, Thomas RE. The place of physical medicine and orthopaedic surgery in leprosy. An investigation into paralysis patterns in the forearm and hand in leprosy. Physiotherapy and neural involvement in leprosy. Suggestions for treatment by physical methods in neural leprosy. Lepr Rev, 1954; 25: 5-41.
39. van Gijn J. Measurement of outcome in stroke prevention trials. Cerebrovasc Dis, 1992; 2: 23-34.
40. Molenaar DSM, de Haan R, Vermeulen M. Impairment,disability,or handicap in peripheral neuropathy: analysis in the use of outcome measures in clinical trials in patients with peripheral neuropathies. J Neurol Neurosurg Psychiatry, 1995; 59: 165-169.